Mangoceuticals, Inc.

MGRX

Exchange: Nasdaq
Industry: Services-Misc Health & Allied Services, NEC
SEC CIK: 0001938046

SEC filings (opens in a new tab)

No open-market purchases or sales by Mangoceuticals, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $455.6K in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Mangoceuticals, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025 All holders in Q1 2025

13F holders of MGRX: Q1 2025 compared with Q2 2025
Measure	Q1 2025	Q2 2025	Change
Holders	8	10	+2
Shares	75.3K	292.3K	+216.9K (+288.0%)
Value	$146.9K	$444.2K	+$297.4K (+202.5%)

New holders (3)

Institutions that held Mangoceuticals, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to MGRX in Q2 2025
Institution	Shares	Value	% of portfolio
Vanguard Group Inc	182,613	$277.6K	0.00%
Renaissance Technologies LLC	31,000	$47.1K	0.00%
Goldman Sachs Group Inc	10,570	$16.1K	0.00%

Sold out (1)

Institutions that held Mangoceuticals, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of MGRX in Q2 2025
Institution	Shares, Q1 2025	Value, Q1 2025
Federation des caisses Desjardins du Quebec	7,100	$13.8K